PPH
VanEck Pharmaceutical ETF
📎 Investment Objective
The VanEck Pharmaceutical ETF (PPH) seeks to track the performance of the MVIS US Listed Pharmaceutical 25 Index, which is intended to give investors exposure to the largest and most liquid pharmaceutical companies listed in the United States.
Overview
ETF tracking VanEck Pharmaceutical ETF
Performance
Price Chart
Investment Summary
📎 Investment Objective
The VanEck Pharmaceutical ETF (PPH) seeks to track the performance of the MVIS US Listed Pharmaceutical 25 Index, which is intended to give investors exposure to the largest and most liquid pharmaceutical companies listed in the United States.
🎯 Investment Strategy
The ETF invests in a portfolio of pharmaceutical stocks that are included in the underlying index. The index is market capitalization-weighted and rebalanced quarterly to maintain exposure to the largest and most liquid pharmaceutical companies.
✨ Key Features
- Provides broad exposure to the U.S. pharmaceutical industry
- Focuses on large, established pharmaceutical companies
- Low expense ratio of 0.00%
- Tracks the MVIS US Listed Pharmaceutical 25 Index
⚠️ Primary Risks
- Concentration risk as the fund is focused on the pharmaceutical sector
- Potential volatility due to the cyclical nature of the pharmaceutical industry
- Regulatory and patent expiration risks that can impact pharmaceutical companies
- Currency risk for investors outside the U.S.
👤 Best For
The VanEck Pharmaceutical ETF may be suitable for investors seeking broad exposure to the U.S. pharmaceutical industry as part of a diversified portfolio. It may be particularly appealing to investors with a long-term investment horizon who are comfortable with the risks associated with the pharmaceutical sector.